PAF mediates cigarette smoke-induced goblet cell metaplasia in guinea pig airways.
Goblet cell metaplasia is an important morphological feature in the airways of patients with chronic airway diseases; however, the precise mechanisms that cause this feature are unknown. We investigated the role of endogenous platelet-activating factor (PAF) in airway goblet cell metaplasia induced by cigarette smoke in vivo. Guinea pigs were exposed repeatedly to cigarette smoke for 14 consecutive days. The number of goblet cells in each trachea was determined with Alcian blue-periodic acid-Schiff staining. Differential cell counts and PAF levels in bronchoalveolar lavage fluid were also evaluated. Cigarette smoke exposure significantly increased the number of goblet cells. Eosinophils, neutrophils, and PAF levels in bronchoalveolar lavage fluid were also significantly increased after cigarette smoke. Treatment with a specific PAF receptor antagonist, E-6123, significantly attenuated the increases in the number of airway goblet cells, eosinophils, and neutrophils observed after cigarette smoke exposure. These results suggest that endogenous PAF may play a key role in goblet cell metaplasia induced by cigarette smoke and that potential roles exist for inhibitors of PAF receptor in the treatment of hypersecretory airway diseases.
Komori
M
M
Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.
Inoue
H
H
Matsumoto
K
K
Koto
H
H
Fukuyama
S
S
Aizawa
H
H
Hara
N
N
D000818:Animals; D001381:Azepines / Q000494:pharmacology; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology; D002452:Cell Count; D004804:Eosinophils / Q000166:cytology / Q000201:enzymology; D020397:Goblet Cells / Q000473:pathology*; D006168:Guinea Pigs; D008297:Male; D008679:Metaplasia; D009195:Peroxidase / Q000378:metabolism; D010947:Plants, Toxic; D010972:Platelet Activating Factor / Q000032:analysis / Q000494:pharmacology / Q000502:physiology*; D010980:Platelet Membrane Glycoproteins / Q000037:antagonists & inhibitors; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D012867:Skin / Q000166:cytology / Q000187:drug effects; D012906:Smoke / Q000009:adverse effects*; D014026:Nicotiana; D014132:Trachea / Q000473:pathology*; D014230:Triazoles / Q000494:pharmacology
D001381:Azepines; D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D012906:Smoke; D014230:Triazoles; C039351:platelet activating factor receptor; C068033:E 6123; D009195:Peroxidase